Stockscreener 앱 받기
19.58
2.10%
-0.42
시간 외 거래:
19.70
0.12
+0.61%
Tonix Pharmaceuticals Holding Corp 주식(TNXP)의 최신 뉴스
Tonix Pharmaceuticals Reveals Promising Preclinical Data for Cancer Immunotherapy TNX-1700 - citybuzz -
Tonix Pharma Unveils Promising Cancer Treatment Data - TipRanks
Tonix Pharmaceuticals Presented Preclinical Data on Gastric - GlobeNewswire
Tonix Pharmaceuticals (TNXP) Showcases Promising Cancer Research at AACR 2025 | TNXP Stock News - GuruFocus
Tonix Pharmaceuticals Presented Preclinical Data on Gastric Canc - GuruFocus
Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting - The Manila Times
Groundbreaking Cancer Therapy Shows Promise: Tonix's New Combination Treatment Activates Cancer-Killing Cells - Stock Titan
Tonix Pharmaceuticals and Makana partner to advance research with Anti-Rejection therapy - Proactive Investors
Tonix Pharmaceuticals Holding CorpDiscontinued Enrollment And Terminated Phase 2 Catalyst StudySEC Filing - marketscreener.com
Tonix Pharmaceuticals Reveals Promising Single-Dose Mpox Vaccine Data - citybuzz -
Tonix reports promising results for mpox vaccine TNX-801 By Investing.com - Investing.com South Africa
Tonix Pharmaceuticals (TNXP) Unveils Promising Results for Single-Dose Mpox Vaccine | TNXP Stock News - GuruFocus
Tonix reports promising results for mpox vaccine TNX-801 - Investing.com
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine T - GuruFocus
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025 - The Manila Times
Tonix Pharmaceuticals Presented Data on Potential Mpox - GlobeNewswire
Tonix Pharma Presents Promising Vaccine Data at Congress - TipRanks
Single-Dose Mpox Vaccine Breakthrough: Complete Protection for Immunocompromised Patients in Latest Trial - Stock Titan
Tonix Pharmaceuticals (TNXP) Falls Despite Market Upturn - GuruFocus
Tonix Pharmaceuticals (TNXP) to Present at World Vaccine Congres - GuruFocus
When the Price of (TNXP) Talks, People Listen - news.stocktradersdaily.com
Tonix Pharmaceuticals Announces Oral Presentation And Panel Participation At The World Vaccine Congress Washington 2025 - marketscreener.com
Tonix Pharmaceuticals Announces Oral Presentation and Panel - GlobeNewswire
Major Breakthrough: Tonix Unveils Single-Dose Mpox Vaccine Data at Leading Global Conference - Stock Titan
Why Tonix Pharmaceuticals Corp. (TNXP) Went Down On Thursday? - MSN
Tonix and Makana partner on xenotransplantation research By Investing.com - Investing.com India
Tonix Pharmaceuticals and Makana Therapeutics Announce Collabora - GuruFocus
Tonix and Makana partner on xenotransplantation research - Investing.com
Tonix Pharmaceuticals and Makana Therapeutics Announce - GlobeNewswire
Tonix Pharmaceuticals And Makana Therapeutics Announce Collaboration Combining Tonix'S Anti-Cd40l Monoclonal Antibody (Tnx-1500) With Makana'S Genetically Engineered Organs In Preclinical And Clinical Xenotransplantation Studies - marketscreener.com
Revolutionary Xenotransplantation Breakthrough: Tonix and Makana Join Forces to Combat Organ Failure - Stock Titan
Tonix Pharmaceuticals launches :TONIX ONE™ A digital breakthrough in migraine management - Proactive financial news
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting - GlobeNewswire
Game-Changing Fibromyalgia Treatment Achieves Phase 3 Success, FDA Decision Looms - Stock Titan
(TNXP) Investment Analysis - news.stocktradersdaily.com
Peering Into Tonix Pharmaceuticals's Recent Short Interest - Benzinga
TNXP: No AdCom Required for TNX-102 SL NDA… - Yahoo Finance
Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference - GlobeNewswire
Tonix Pharmaceuticals Reveals 5 Major Catalysts: FDA Decision, DoD Contract, and Breakthrough Therapies - Stock Titan
Tonix Pharmaceuticals launches migraine management platform By Investing.com - Investing.com South Africa
Tonix Pharmaceuticals Launches TONIX ONE™, a - GlobeNewswire
Tonix Pharma stock rises following TONIX ONE launch By Investing.com - Investing.com South Africa
Tonix Pharma stock rises following TONIX ONE launch - Investing.com Australia
Tonix Pharmaceuticals launches migraine management platform - Investing.com
Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition - GlobeNewswire
Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Lat - PharmiWeb.com
Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year - ACCESS Newswire
Revolutionary Non-Opioid Pain Drug Could Transform Fibromyalgia Treatment by 2025 - Stock Titan
New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc. - Bluefield Daily Telegraph
(TNXP) Long Term Investment Analysis - Stock Traders Daily
Tonix Pharmaceuticals Announces Presentation at the - GlobeNewswire
0.39%
3.66%
자본화:
|
볼륨(24시간):